Jim Hartle
Hartford, CT (USA)
Role(s):
Select
Pathway Surgical
Find More Startups
Startup
Location:
Hartford
Industry:
Bio-Technology
Year Founded:
2006
Number Employees:
10-50 people
Description:
Contract medical device components, manufactured in low-cost offshore setting, combined with private label finished implantable devices, positions company to grow from $3.5M FY ‘10 revenue to $25M+ revenue forecast in 2014
•Existing profitable Coronary Stent product line with disruptive unique technology in development (Polymer Free Drug Eluting Coronary Stent)
-Capturing 1/2 of 1% of OUS market would represent $19M in gross revenue from this platform in 2013
•Emerging presence as Nitinol wire component contract manufacturer positions company as outsourcing partner of choice for Tier 1 and Tier 2 U.S. and European based manufacturers of wire based stents, IVCF (Inferior Vena Cava Filters), Embolic Protection Devices, complex shape set components
-Forecasted revenue for wire based components/products estimated at $7.6M USD in 2013
•Existing profitable PTCA Catheter platform with significant growth potential in China, India, Eastern Europe, and OUS markets
•Significant licensing potential with products in development pipeline; Wound Closure (electrical spinning technology for bio absorbable nanofiber plug), unique Nitinol PTCA Guidewire, Polymer Free DES, Nitinol Percutaneous Aortic Valve Replacement Therapy